1. Show article details.

    BRIEF-ResMed Says Airfit F30i Is Now Available In United States, Canada, And Most Of Europe

    Reuters – 9:20 AM ET 01/20/2020

    ResMed Inc (RMD): * ResMed Inc (RMD) - AIRFIT F30I IS NOW AVAILABLE IN UNITED STATES, CANADA, AND MOST OF EUROPE Source text for Eikon: Further company coverage:

  2. Show article details.

    ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask

    Business Wire – 9:00 AM ET 01/20/2020

    ResMed (RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market. This press release features multimedia. Full face CPAP users can now choose between a tube-up or tube-down connection, compact under-the-nose or traditional over-the-nose cushion styles, and even memory foam versus silicone cushion.

  3. ResMed started at perform at Oppenheimer

    MarketWatch – 8:53 AM ET 01/10/2020
  4. Show article details.

    ResMed to Report Second Quarter Fiscal 2020 Earnings on January 30, 2020

    Business Wire – 4:05 PM ET 01/09/2020

    ResMed (RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2020 on Thursday, January 30, 2020, after the New York Stock Exchange closes. Earnings webcast details: Please note that ResMed (RMD) does not use outside phone lines to access the earnings call.

  5. Show article details.

    ResMed Announces Participation in the 38th Annual J.P. Morgan Healthcare Conference

    Business Wire – 9:00 AM ET 01/06/2020

    ResMed (RMD) today announced that Mick Farrell, chief executive officer, will present at the 38th Annual J.P. Morgan Annual Healthcare Conference on Monday, January 13, 2020, beginning at approximately 8:30 a.m. at Westin St. Francis in San Francisco, CA. More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be ava...

  6. Show article details.

    Globus Medical Announces Board of Director Addition and Departure

    GlobeNewswire – 4:15 PM ET 12/13/2019

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019. Mr. Douglas has nearly thirty years of experience in medical device technology, with particular expertise in digital health.

  7. Show article details.

    COPD Outcomes Improved Significantly When Patients and Doctors Used a Digital Health Tool, Propeller Health Study Finds

    Business Wire – 6:00 AM ET 11/25/2019

    Patients at Louisville’s JenCare Senior Medical Center saw decreases in rescue medication use and increases in days without rescue use over a 12-month period Patients with chronic obstructive pulmonary disease at Louisville’s JenCare Senior Medical Center, a ChenMed company, saw their health outcomes improve significantly when their primary care physicians encouraged using Propeller’s digital h...

  8. ResMed started at sector weight at KeyBanc Capital

    MarketWatch – 8:22 AM ET 11/22/2019
  9. Show article details.

    Propeller Health Users Can Now Access Pharmacy Services From CVS, Walmart, Kroger and Rite-Aid From Within the Propeller App

    Business Wire – 9:00 AM ET 11/19/2019

    With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with five of the seven largest pharmaceutical providers in the U.S.

  10. Show article details.

    Propeller Users Can Now Locate Their Lost Inhaler by “Ringing” Their Propeller Sensor From the App

    Business Wire – 9:00 AM ET 10/29/2019

    Find My Inhaler update puts patient feedback into practice, making it easier for users to quickly find their misplaced inhaler Starting today, Propeller users will be able to “ring” the sensor on a misplaced inhaler to make it easier to find, through an update to the Find My Inhaler feature in the Propeller app. This press release features multimedia.

  11. Show article details.

    ResMed Announces Participation in the Credit Suisse 28th Annual Healthcare Conference

    Business Wire – 9:00 AM ET 10/29/2019

    ResMed (RMD) today announced that Rob Douglas, chief operating officer, will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019, beginning at approximately 9:10 a.m. at The Phoenician in Scottsdale, AZ. More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available appr...

  12. Show article details.

    Cerner and ResMed Join Forces to Connect Health Networks and the Home

    GlobeNewswire – 9:00 AM ET 10/07/2019

    Cerner Corporation (CERN), a global health platform and innovation company, and ResMed (RMD), a world-leading digital health company, today announced a new collaboration agreement to help providers make more informed treatment decisions, control costs and deliver seamless care across health systems to the home.

Page:

Today's and Upcoming Events

  • Jan
    30

    RMD to announce Q2 earnings (Confirmed)

Past Events (last 90 days)

  • Nov
    06

    RMD ex-Dividend for $0.39 on 11/06/2019

    • Announce Date: 10/24/2019
    • Record Date: 11/07/2019
    • Pay Date: 12/12/2019
  • Oct
    24

    RMD announced Q1 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.